Abstract
The anabolic-androgen steroids (AAS) are chemicals that have both properties contained in the same molecule. Therefore, it is impossible to discuss one type of action without including the other because the effects of intoxication from these compounds are both anabolic and androgenic. Anabolic action is the performance-enhancing and muscle-mass-proliferation property, whereas the androgenic action is characteristic of male sex hormones. The pharmacological objective in use by athletes is to promote the anabolic or performance-enhancing effect while attempting to minimize the androgenic effect.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Redda KK, Walker CA, Barnett G (1989). Cocaine, Marijuana, Designer Drugs: Chemistry, Pharmacology and Behavior. Boca Raton, FL: CRC Press.
Haupt HA, Rovere GD (1984). Anabolic steroids: A review of the literature. Am J Sports Med12:469–484.
Kochakian CD, Murlin JR (1935). The effect of male hormone on problem and energy metabolism of castrated dogs. J Nutr10:437.
Kopera H (1985). The history of anabolic steroids and a review of clinical experience with anabolic steroids. Acta Endocrinol (Suppl)271:11–18.
Wilson JD (1988). Androgen abuse by athletes. Endocrinol Rev9:181–199.
Lamb DR (1984). Anabolic steroids in athletics: How well do they work and how dangerous are they? Am J Sports Med12:31–38.
Murad F, Haynes RC (1985). Androgens. In The Pharmacological Basis of Therapeutics, Gilman AG, Goodman LS, Rail TW, Murad F, eds. New York: Macmillan.
Rogers HJ, Spector RG, Trounce JR (1981). A Textbook of Clinical Pharmacology. London: Hodder and Stoughton.
Council on Scientific Affairs (1988). Drug abuse in athletes: Anabolic steroids and human growth hormone. JAMA259:1703–1705.
Buckley WE, Yesalis CE, Friedl K, et al. (1988). Estimated prevalence of anabolic steroid use among male high school seniors. JAMA260:3441–3445.
Dezelsky TL, Toohey JV, Shaw RS (1985). Non-medical drug use behavior at five United States universities: 1 15-year study. Bull Narc37 (2–3): 49–53.
Coward V (1987). Steroids in sports: After four decades, time to return these genies to bottle? JAMA257:421–427.
Bergman R, Leach RE (1985). The use and abuse of anabolic steroids in Olympic-caliber athletes. Clin Orthop Relat Res198:169–172.
Frankle MA, Cicero GJ, Payne J (1984). Use of androgenic anabolic steroids by athletes. JAMA252:482.
Pope HG Jr, Katz DL, Champoux R (1988). Anabolic-androgenic steroid use among 1,010 college men. Physician Sportsmed16:75–81.
Pope HG Jr, Katz DL (1988). Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry145: 487–490.
Gower DB (1979). Steroid Hormones. London: Croom Helm.
Van Wayjen RGA, Buyze G (1962). Clinical pharmacological evaluation of certain anabolic steroids. Acta Endocrinol (Suppl)63:18.
Griffin JE, Wilson JD (1985). Disorders of the testes and male reproductive tract. In Textbook of Endocrinology, Wilson JD, Foster DW, eds., pp. 259–311. Philadelphia: Saunders.
Desauller PA, Krahenbhl C (1962). Evaluation and mode of action of anabolic steroids: Differentiation of action of various anabolic steroids. In Protein Metabolism, p. 185. Berlin: Springer-Verlag.
Smith RG, Nag A, Syms AL, Norris JSH (1986). Steroid receptor, gene structure and molecular biology. J Steroid Biochem214:51.
Tepperman J (1973). Metabolic and Endocrine Physiology, p. 70. Chicago: Yearbook Medical Publisher.
Nowakowski H (1962). Metabolic studies with anabolic steroids. Acta Endocrinol (Suppl)63:37.
Kibble MW, Ross MB (1987). Adverse effects of anabolic steroids in athletes. Clin Pharm6:686–692.
McNutt RA, Ferenchick GS, Kirlin PC, et al. (1988). Acute myocardial infarction in a 22-year-old world-class weight lifter using anabolic steroids. Am J Cardiol62:164.
Mochizuki RH, Richter KJ (1988). Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Physician Sportsmed16:109–114.
Ishak KG, Zimmerman HJ (1987). Hepatotoxic effects of the anabolic/andro-genic steroids. Semin Liver Dis7:230–236.
Creagh TM, Rubin A, Evans DJ (1988). Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol 41.-441–443.
APA (1987). DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, Washington, DC: American Psychiatric Association.
Brower KJ, Blow FC, Beresford TP, Fuelling C (1989). Anabolic-androgenic steroid dependence. J Clin Psychiatry50:31–33.
Hatton CK, Catlin DH (1987). Detection of androgenic anabolic steroids in urine. Clin Lab Med7:655–668.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag New York
About this chapter
Cite this chapter
Miller, N.S. (1991). The Pharmacology of Anabolic-Androgen Steroids. In: The Pharmacology of Alcohol and Drugs of Abuse and Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3044-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3044-1_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7774-3
Online ISBN: 978-1-4612-3044-1
eBook Packages: Springer Book Archive